MRNA

Moderna

$30.28

+1.59 (+5.54%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 03.07.2025
$47.59
(+57.17%)
Strong Buy: 1
Buy: 5
Hold: 17
Sell: 1
Strong Sell: 3
Description:
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Exchange:
NASDAQ
Country:
USA
Sector:
LIFE SCIENCES
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US
Fiscal year end:
December
Market capitalization:
$11.1 Billion
EBITDA:
-$3.54 Billion
PERatio:
0.0
EPS:
-9.08
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.859

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 7 years:
+48%
How much will you get:
$1,483
Prices dates:
07-12-2018: $18.60 and 30-06-2025: $27.59